Joint Meeting of the Coverage Joint Meeting of the Coverage and Future Vaccines and Future Vaccines

SubcommitteesSubcommittees

Joint Meeting of the Coverage Joint Meeting of the Coverage and Future Vaccines and Future Vaccines

SubcommitteesSubcommittees

October 5, 2004October 5, 2004

Joint Meeting of the Coverage and Joint Meeting of the Coverage and Future Vaccines SubcommitteesFuture Vaccines Subcommittees

October 5, 2004October 5, 2004

Rationale:Rationale:– in view of future vaccines being in view of future vaccines being

developed for use in adolescents, there developed for use in adolescents, there are concerns about the capacity to reach are concerns about the capacity to reach and immunize the majority of adolescentsand immunize the majority of adolescents

Purpose:Purpose:– Seek comment and collaboration in the Seek comment and collaboration in the

planning of a National Stakeholder Meeting planning of a National Stakeholder Meeting on Strategies to Increase the Uptake of on Strategies to Increase the Uptake of New Vaccines for AdolescentsNew Vaccines for Adolescents

Future VaccinesFuture Vaccines

MCVMCVTdapTdapHPVHPVHSVHSVCMVCMVHIVHIV

Previous NVAC Efforts in Previous NVAC Efforts in Adolescent ImmunizationAdolescent Immunization

1996 - Adolescent Immunization 1996 - Adolescent Immunization WorkshopWorkshop

1996 – Summary Report of Workshop 1996 – Summary Report of Workshop on Adolescent Immunizationon Adolescent Immunization– Recommendations not implemented due Recommendations not implemented due

to lack of identifiable resourcesto lack of identifiable resources

1996 – MMWR publication 1996 – MMWR publication “Immunization of Adolescents”“Immunization of Adolescents”

Summary of NFID Meeting on Summary of NFID Meeting on Adolescent Immunization, 8/04Adolescent Immunization, 8/04

Roundtable discussion of issues and Roundtable discussion of issues and strategies chaired by Dr. W. Schaffnerstrategies chaired by Dr. W. Schaffner– Identification of barriersIdentification of barriers

– Identify best practices and successful Identify best practices and successful model programsmodel programs

– School based requirementsSchool based requirements

– Public education and awarenessPublic education and awareness

– Vaccine costVaccine cost

– PartnershipsPartnerships

Summary of NFID Meeting on Summary of NFID Meeting on Adolescent ImmunizationAdolescent Immunization

NFID Monograph to be published on NFID Monograph to be published on the Roundtable discussion of the Roundtable discussion of exploration and awareness of issues exploration and awareness of issues surrounding adolescent immunizationsurrounding adolescent immunization

Adolescent Stakeholders MeetingAdolescent Stakeholders MeetingGoalsGoals

Identify the strengths and weaknesses of key Identify the strengths and weaknesses of key implementation strategies and issuesimplementation strategies and issues

Identify approaches that will effectively and Identify approaches that will effectively and efficiently increase the proportion of adolescents efficiently increase the proportion of adolescents who receive vaccineswho receive vaccines

Develop plans to implement these approachesDevelop plans to implement these approaches Identify research initiativesIdentify research initiatives

– Support the successful introductionSupport the successful introduction

– Accelerate development of vaccines in the 'pipeline'Accelerate development of vaccines in the 'pipeline'

Adolescent Stakeholders MeetingAdolescent Stakeholders MeetingKey Strategies and IssuesKey Strategies and Issues

Delivery systems and settingsDelivery systems and settings

Communications strategiesCommunications strategies

Research initiatives for future vaccinesResearch initiatives for future vaccines

Integration with other adolescent health Integration with other adolescent health prioritiespriorities

Financing and other important barriersFinancing and other important barriers

Adolescent Stakeholders MeetingAdolescent Stakeholders MeetingKey Strategies and IssuesKey Strategies and Issues

Immunization regulations and other Immunization regulations and other mandatesmandates

ConsentConsent

Appropriate roles and responsibilities Appropriate roles and responsibilities (local, state, and federal)(local, state, and federal)

Novel vaccine delivery systemsNovel vaccine delivery systems

Key StrategyKey StrategyDelivery Systems and SettingsDelivery Systems and Settings

In which combination of delivery systems In which combination of delivery systems and settings can the new adolescent and settings can the new adolescent vaccines best be implemented?vaccines best be implemented?

– In the medical homeIn the medical home

– Outside the medical homeOutside the medical home

– Non-traditional settingsNon-traditional settings

– SchoolsSchools

Key StrategyKey StrategyCommunication StrategiesCommunication Strategies

What communications strategies are What communications strategies are most appropriate and effective?most appropriate and effective?

– How should parents be informed?How should parents be informed?

– How should patients be informed?How should patients be informed?

– How should providers be informed?How should providers be informed?

Key StrategyKey StrategyResearch InitiativesResearch Initiatives

What should the research agenda be for What should the research agenda be for future vaccines for adolescents?future vaccines for adolescents?

What is the role of novel vaccine delivery What is the role of novel vaccine delivery systems (i.e., needle-less systems) for systems (i.e., needle-less systems) for delivery of vaccines to adolescents?delivery of vaccines to adolescents?

Key StrategyKey StrategyIntegration with other Adolescent Integration with other Adolescent

Health PrioritiesHealth Priorities

How can vaccination be integrated How can vaccination be integrated with other adolescent health with other adolescent health priorities?priorities?

– Anticipatory guidanceAnticipatory guidance

– Injury preventionInjury prevention

– Prevention of drug and alcohol usePrevention of drug and alcohol use

Key StrategyKey StrategyVaccine FinancingVaccine Financing

How should adolescent vaccination How should adolescent vaccination efforts be financed?efforts be financed?– Identification of resourcesIdentification of resources

Key StrategyKey StrategyImmunization regulations and Immunization regulations and

other mandatesother mandates

When and how should immunization When and how should immunization regulations and other mandates be used regulations and other mandates be used to increase the uptake of new vaccines?to increase the uptake of new vaccines?

Key StrategyKey StrategyConsent IssuesConsent Issues

Are there new approaches to obtaining Are there new approaches to obtaining consent?consent?

– What laws enable minors to consent to What laws enable minors to consent to treatment and prevention services in the treatment and prevention services in the U.S.? U.S.?

– What is the current and potential use of What is the current and potential use of these laws to enable self-consent for these laws to enable self-consent for adolescent immunization?adolescent immunization?

– Can a single consent be flexible, e.g. Can a single consent be flexible, e.g. covering multiple vaccinations with a single covering multiple vaccinations with a single consent form?consent form?

Key StrategyKey StrategyBarriersBarriers

What are the barriers?What are the barriers? Which other barriers are most important Which other barriers are most important

to the health care system, providers, and to the health care system, providers, and patients?patients?

– e.g. missed opportunities, lack of knowledge e.g. missed opportunities, lack of knowledge (patients and providers), cost(patients and providers), cost

Adolescent Stakeholders MeetingAdolescent Stakeholders Meeting Key StrategyKey Strategy

What are the appropriate roles and What are the appropriate roles and responsibilities of local, state, and responsibilities of local, state, and federal public health officials?federal public health officials?

List of StakeholdersList of Stakeholders

Provider organizations, ie AAP, SAM, Provider organizations, ie AAP, SAM, AAFP, AMA, NMA, ANA, etc.AAFP, AMA, NMA, ANA, etc.

Non-pediatric provider organizationsNon-pediatric provider organizations– ACOG, STD Clinics, etc..ACOG, STD Clinics, etc..

NGO’sNGO’s Vaccine manufacturersVaccine manufacturers Federal, local and state public health Federal, local and state public health

agenciesagencies

Stakeholder MeetingStakeholder Meeting

Venue: Washington DCVenue: Washington DC Time: June 2005Time: June 2005 Duration: 2 day meetingDuration: 2 day meeting

Stakeholder Meeting Stakeholder Meeting Organizing CommitteeOrganizing Committee

TBA; volunteers neededTBA; volunteers needed Consider a CoSponsor for the Consider a CoSponsor for the

meeting, i.e. SAMmeeting, i.e. SAM Include adolescent specialists from Include adolescent specialists from

SAM, AAP, ACIP, CDC, etc.. SAM, AAP, ACIP, CDC, etc..